Author

Yiluan Ding

Chinese Academy of Sciences

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:protein sequence· 1 Research Focus:sequence-to-function modeling· 1 Approach:transformer / foundation model· 1

Frequent Co-Authors

Chen Zheng· 1 shared Chenmao Zhou· 1 shared Hao GuoiD· 1 shared Hualiang JiangiD· 1 shared Jie ChangiD· 1 shared Keke ZhangiD· 1 shared Lifan CheniD· 1 shared Mingyue ZhengiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Chen Zheng

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Drug design and repurposing with a sequence-to-drug paradigm

Lifan Chen, Zisheng Fan, Jie Chang, Ruirui Yang, Hao Guo, Yinghui Zhang, Tianbiao Yang, Chenmao Zhou, Zhengyang Chen, Chen Zheng, Xinyue Hao, Keke Zhang, Rongrong Cui, Yiluan Ding, Naixia Zhang, , Mingyue Zheng

This paper introduces a sequence-to-drug paradigm using TransformerCPI2.0 to discover drug-like molecules from protein sequences and validates its effectiveness for three targets.

bioRxiv · Mar 26, 2022 · PreprintMolecular Biology